Literature DB >> 7054591

Correlation of fatty acyl composition of mitochondrial and microsomal phospholipid with growth rate of rat hepatomas.

J W Hartz, R E Morton, M M Waite, H P Morris.   

Abstract

This paper presents fatty acyl compositions of phospholipids derived from mitochondria and microsomes isolated from two Morris hepatomas, one with slow (9618A) and another with intermediate (7794A) growth rate, and from corresponding host livers. These were compared with previous data from our laboratory for the fast-growing Morris hepatoma 7777. In this group of three hepatomas of widely differing growth rate and differentiation, the faster the growth rate of the tumor, the larger the sum of the contents of 16:1, 18:1, and 18:2 and the smaller the sum of the contents of all polyunsaturated fatty acids with four or more double bonds per molecule. The former sum was generally higher and the polyunsaturate content lower in hepatoma organelles than in corresponding host liver organelles. The 18:0/18:1 ratio observed in hepatoma organelles was always significantly less than that in host or control liver organelles.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054591

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  11 in total

1.  Changes in liver fatty acid unsaturation after partial hepatectomy in the rat.

Authors:  T Kishino; M Tanno; H Yamada; S Saito; S Matsumoto
Journal:  Lipids       Date:  2000-04       Impact factor: 1.880

2.  Vitamin B6 deficiency in new born rats affects hepatic cardiolipin composition and oxidative phosphorylation.

Authors:  Carmen Wolke; Sarah Gürtler; Daniela Peter; Jens Weingärtner; Grazyna Domanska; Uwe Lendeckel; Lorenz Schild
Journal:  Exp Biol Med (Maywood)       Date:  2019-11-21

3.  Lipidomic analysis of molecular cardiolipin species in livers exposed to ischemia/reperfusion.

Authors:  Jan-Christian Martens; Gerburg Keilhoff; Walter Halangk; Thomas Wartmann; Andreas Gardemann; Ilona Päge; Lorenz Schild
Journal:  Mol Cell Biochem       Date:  2014-11-23       Impact factor: 3.396

4.  Differences in the long chain (sphingoid) base composition of sphingomyelin from rats bearing Morris hepatoma 7777.

Authors:  A H Merrill; E Wang; P W Wertz
Journal:  Lipids       Date:  1986-08       Impact factor: 1.880

5.  Vaccenic acid (t11-18:1) is converted to c9,t11-CLA in MCF-7 and SW480 cancer cells.

Authors:  Aine Miller; Emma McGrath; Catherine Stanton; Rosaleen Devery
Journal:  Lipids       Date:  2003-06       Impact factor: 1.880

6.  Alteration of the lipid profile in lymphomas induced by MYC overexpression.

Authors:  Livia S Eberlin; Meital Gabay; Alice C Fan; Arvin M Gouw; Robert J Tibshirani; Dean W Felsher; Richard N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-03       Impact factor: 11.205

7.  Incorporation and metabolic conversion of saturated and unsaturated fatty acids in SK-Hep1 human hepatoma cells in culture.

Authors:  C A Marra; M J de Alaniz
Journal:  Mol Cell Biochem       Date:  1992-11-18       Impact factor: 3.396

8.  Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Jeffrey H Chuang; Thomas N Seyfried
Journal:  J Lipid Res       Date:  2008-08-13       Impact factor: 5.922

Review 9.  Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products.

Authors:  Giuseppina Barrera; Fabrizio Gentile; Stefania Pizzimenti; Rosa Angela Canuto; Martina Daga; Alessia Arcaro; Giovanni Paolo Cetrangolo; Alessio Lepore; Carlo Ferretti; Chiara Dianzani; Giuliana Muzio
Journal:  Antioxidants (Basel)       Date:  2016-02-19

10.  In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Thomas N Seyfried
Journal:  ASN Neuro       Date:  2009-05-27       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.